’ equity Issued and paid-up 400.00 400.00 - 0.00% Premium on paid-up capital 305.53 305.53 - 0.00% Share surplus from business combination under common control 20.64 20.64 - 0.00% Retained earnings 78.02

instruments and cannot be compared with the financial statements of 2020. However, the cumulative effect of initially applying these standards is recognized as an adjustment to retained earnings as at January 1

that will support continuous growth momentum in demand for medical devices in Thailand. In 2019, the Company has improved and increased the sales team to increase sales efficiency in distributor of

% 524 472 -10% Net profit for the period 904 33% 1,828 2,018 10% 2,322 2,037 -12% Earnings Per Share (Baht per share) 3.61 33% 7.31 8.07 10% 9.29 8.15 -12% 3 Sales and Revenues Structure for the first

% Net profit for the period 692 -37.1% 3,553 3,815 7.4% 4,133 3,711 -10.2% Earnings Per Share (Baht per share) 2.77 -37.3% 14.21 15.26 7.4% 16.53 14.84 -10.2% 3 Sales and Revenues Structure for the fiscal

stimulus policies worth Baht 464 billion to support domestic spending, the property market and grassroots economy. Meanwhile, tourist arrivals rose by 4.2 percent, softening from 7.3 percent in 2018. A

in support of the national policy of making Thailand a cashless society. We always strive to bolster our capabilities in providing services via digital channels to promote increased digital

actively find opportunity for new potential investment driven its business growth compatible with strengthen the revenue structure and support sustainable growth strategy. In 2019, the Company progressed

possible conflict of interests To sustain the company’s operations under the prevailing severe competitive situation, the company needed to secure the support of business partners and business alliance

December 2018 thanks to strong support from our shareholders. In May 2018, BGRIM was also selected to be in the ESG100 list (Environmental, Social and Governance) by Thaipat Institute to reflect the company